These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30214068)

  • 21. Parents' understanding of genome and exome sequencing for pediatric health conditions: a systematic review.
    Gereis J; Hetherington K; Ha L; Robertson EG; Ziegler DS; Barlow-Stewart K; Tucker KM; Marron JM; Wakefield CE
    Eur J Hum Genet; 2022 Nov; 30(11):1216-1225. PubMed ID: 35999452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling.
    Smith LA; Douglas J; Braxton AA; Kramer K
    J Genet Couns; 2015 Aug; 24(4):654-62. PubMed ID: 25403901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Criteria for reporting incidental findings in clinical exome sequencing - a focus group study on professional practices and perspectives in Belgian genetic centres.
    Saelaert M; Mertes H; Moerenhout T; De Baere E; Devisch I
    BMC Med Genomics; 2019 Aug; 12(1):123. PubMed ID: 31429751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing.
    Evans BJ
    Genet Med; 2013 Dec; 15(12):915-20. PubMed ID: 24030435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics: Fluent in DNA.
    Eisenstein M
    Nature; 2015 Oct; 526(7571):151-2. PubMed ID: 26443869
    [No Abstract]   [Full Text] [Related]  

  • 26. Informed consent for exome sequencing research in families with genetic disease: the emerging issue of incidental findings.
    Bergner AL; Bollinger J; Raraigh KS; Tichnell C; Murray B; Blout CL; Telegrafi AB; James CA
    Am J Med Genet A; 2014 Nov; 164A(11):2745-52. PubMed ID: 25251809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic sequencing identifies secondary findings in a cohort of parent study participants.
    Thompson ML; Finnila CR; Bowling KM; Brothers KB; Neu MB; Amaral MD; Hiatt SM; East KM; Gray DE; Lawlor JMJ; Kelley WV; Lose EJ; Rich CA; Simmons S; Levy SE; Myers RM; Barsh GS; Bebin EM; Cooper GM
    Genet Med; 2018 Dec; 20(12):1635-1643. PubMed ID: 29790872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opt-in for secondary findings as part of diagnostic whole-exome sequencing: Real-life experience from an international diagnostic laboratory.
    Brunfeldt M; Kaare M; Saarinen I; Koskenvuo J; Kääriäinen H
    Mol Genet Genomic Med; 2023 Aug; 11(8):e2180. PubMed ID: 37025058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACMG Releases Guidelines for Exome and Genome Sequencing for Pediatric Patients.
    Am J Med Genet A; 2021 Nov; 185(11):3185-3186. PubMed ID: 34655171
    [No Abstract]   [Full Text] [Related]  

  • 30. Genomics really gets personal: how exome and whole genome sequencing challenge the ethical framework of human genetics research.
    Tabor HK; Berkman BE; Hull SC; Bamshad MJ
    Am J Med Genet A; 2011 Dec; 155A(12):2916-24. PubMed ID: 22038764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ethical issues in genome-era].
    Kosugi S
    Nihon Rinsho; 2016 Jun; 74(6):1022-7. PubMed ID: 27311196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort study.
    Shickh S; Gutierrez Salazar M; Zakoor KR; Lázaro C; Gu J; Goltz J; Kleinman D; Noor A; Khalouei S; Mighton C; Reble E; Kodida R; Bombard Y; DiTroia S; Baxter S; Watkins N; Care M; Adler A; Horsburgh S; Morar O; Murphy J; Nevay DL; Szybowska M; Aronson M; Panchal S; Godoy R; Holter S; Randall Armel S; Semotiuk K; Elser C; Kim RH; Chitayat D; So J; Faghfoury H; Silver J; Morel CF; Lerner-Ellis J
    J Med Genet; 2021 Apr; 58(4):275-283. PubMed ID: 32581083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencing.
    Godino L; Varesco L; Bruno W; Bruzzone C; Battistuzzi L; Franiuk M; Miccoli S; Bertonazzi B; Graziano C; Seri M; Turchetti D
    J Genet Couns; 2021 Jun; 30(3):665-675. PubMed ID: 33142017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Return of non-ACMG recommended incidental genetic findings to pediatric patients: considerations and opportunities from experiences in genomic sequencing.
    Bowling KM; Thompson ML; Kelly MA; Scollon S; Slavotinek AM; Powell BC; Kirmse BM; Hendon LG; Brothers KB; Korf BR; Cooper GM; Greally JM; Hurst ACE
    Genome Med; 2022 Nov; 14(1):131. PubMed ID: 36414972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation among Consent Forms for Clinical Whole Exome Sequencing.
    Fowler SA; Saunders CJ; Hoffman MA
    J Genet Couns; 2018 Feb; 27(1):104-114. PubMed ID: 28689263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommendations for returning genomic incidental findings? We need to talk!
    Burke W; Antommaria AH; Bennett R; Botkin J; Clayton EW; Henderson GE; Holm IA; Jarvik GP; Khoury MJ; Knoppers BM; Press NA; Ross LF; Rothstein MA; Saal H; Uhlmann WR; Wilfond B; Wolf SM; Zimmern R
    Genet Med; 2013 Nov; 15(11):854-9. PubMed ID: 23907645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correspondence on "ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)" by Miller et al.
    McGurk KA; Zheng SL; Henry A; Josephs K; Edwards M; de Marvao A; Whiffin N; Roberts A; Lumbers TR; O'Regan DP; Ware JS
    Genet Med; 2022 Mar; 24(3):744-746. PubMed ID: 34906520
    [No Abstract]   [Full Text] [Related]  

  • 38. A comprehensive iterative approach is highly effective in diagnosing individuals who are exome negative.
    Shashi V; Schoch K; Spillmann R; Cope H; Tan QK; Walley N; Pena L; McConkie-Rosell A; Jiang YH; Stong N; Need AC; Goldstein DB;
    Genet Med; 2019 Jan; 21(1):161-172. PubMed ID: 29907797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests.
    Thauvin-Robinet C; Thevenon J; Nambot S; Delanne J; Kuentz P; Bruel AL; Chassagne A; Cretin E; Pelissier A; Peyron C; Gautier E; Lehalle D; Jean-Marçais N; Callier P; Mosca-Boidron AL; Vitobello A; Sorlin A; Tran Mau-Them F; Philippe C; Vabres P; Demougeot L; Poé C; Jouan T; Chevarin M; Lefebvre M; Bardou M; Tisserant E; Luu M; Binquet C; Deleuze JF; Verstuyft C; Duffourd Y; Faivre L
    Eur J Hum Genet; 2019 Aug; 27(8):1197-1214. PubMed ID: 31019283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-frequency actionable pathogenic exome variants in an average-risk cohort.
    Rego S; Dagan-Rosenfeld O; Zhou W; Sailani MR; Limcaoco P; Colbert E; Avina M; Wheeler J; Craig C; Salins D; Röst HL; Dunn J; McLaughlin T; Steinmetz LM; Bernstein JA; Snyder MP
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30487145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.